ABSTRACT
Objective To investigate the distribution and antibiotic resistance profile of clinical isolates in the First Hospital of Qiqihar during 2015.Methods Antimicrobial susceptibility test was carried out according to a unified protocol using automated system from January 1,2015 to December 31,2015.The results were analyzed with WHONET 5.6 software according to the 2014 breakpoints of Clinical and Laboratory Standards Institute.Results A total of 5 162 clinical isolates were collected,of which 28.1％ (1 450/5 162) were gram-positive cocci and 71.9％ (3 712/5 162) were gram-negative bacilli.About 36.5％ (255/698) ofS.aureus isolates and 81.4％ (180/221) of coagulase negative Staphylococcus isolates were resistant to methicillin.No S.aureus and coagulase negative Staphylococcus isolate were found resistant to vancomycin or linezolid.Enterococcus isolates showed low resistance to vancomycin and linezolid.One strain of E.faecium was found resistant to vancomycin.ESBLs were produced in 39.9％ (298/747) ofE.coli,26.1％ (294/1 127) ofKlebsiella spp.,and 15.6％ (12/77) ofP mirabilis strains.The Enterobacteriaceae strains were less resistant to imipenem,beta-lactam/beta-lactamase inhibitor combination and amikacin.About 36.6％ (163 / 445) of A.baumannii isolates and 1.8％ (13/715) of P.aeruginosa isolates were extensively drug-resistant strains.Conclusions Antibiotic resistance poses a serious threat to clinical practice,to which more attention should be paid.Clinical microbiology lab should make more efforts to provide better support to clinical therapy.
ABSTRACT
Objective To collecct clinical isolates of Klebsiella pneumonia ,detect the sensitivity of antibiotics,determine the characterization of ESBLs-producing strains,type the isolates by PFGE and investingate the clinical data for analysis. Methods ESBLs-producing strains were tested by inhibitor potentiated disk diffusion rcommended by CLSI2015. The susceptibility to 26 different kinds of antibiotics were testd by CLSI2015 disk diffusion method. The typing of the gene of strains by PFGE was analyzed. Results Sixty ESBLs strains produced in 115 strains of Klebsiellapneumoniae ,which was 100% sensitive to imipenem and meropenem in antimicrobial susceptibility ,and were basically resistant to Amoxacillin ,ampicillin ,piperacillin and the first to the fourth generation of cephalosporins. The 60 ESBLs-producing Klebsiellapneumoniae gene was divided into 14 types (A ~ N)by PFGE,of which type A was the epidemic strain(35%,21/60). Conclusion The incidence rate of ESBLs-producing strains is high in respiratory ward in severe resistant multiantibioticsThe epidemic caused by homologusKlebsiella pneumonia can happen. PFGE is a stable and reliable method in searching the source of noso-comial infecton and is suitable for surveillance in the homologus nosocomial infecton.
ABSTRACT
Objective To collecct clinical isolates of Klebsiella pneumonia ,detect the sensitivity of antibiotics,determine the characterization of ESBLs-producing strains,type the isolates by PFGE and investingate the clinical data for analysis. Methods ESBLs-producing strains were tested by inhibitor potentiated disk diffusion rcommended by CLSI2015. The susceptibility to 26 different kinds of antibiotics were testd by CLSI2015 disk diffusion method. The typing of the gene of strains by PFGE was analyzed. Results Sixty ESBLs strains produced in 115 strains of Klebsiellapneumoniae ,which was 100% sensitive to imipenem and meropenem in antimicrobial susceptibility ,and were basically resistant to Amoxacillin ,ampicillin ,piperacillin and the first to the fourth generation of cephalosporins. The 60 ESBLs-producing Klebsiellapneumoniae gene was divided into 14 types (A ~ N)by PFGE,of which type A was the epidemic strain(35%,21/60). Conclusion The incidence rate of ESBLs-producing strains is high in respiratory ward in severe resistant multiantibioticsThe epidemic caused by homologusKlebsiella pneumonia can happen. PFGE is a stable and reliable method in searching the source of noso-comial infecton and is suitable for surveillance in the homologus nosocomial infecton.